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Abstract 
 The 27-item Intolerance of Uncertainty Scale (IUS: Freeston et al., 1994) has become 
one of the most frequently used measure of Intolerance of Uncertainty. More recently, 
an abridged, 12-item version of the IUS has been developed (Carleton, Norton, & 
Asmundson, 2007). The current research used clinical (n=50) and non-clinical (n=56) 
samples to examine and compare the psychometric properties of both versions of the 
IUS. The two scales showed good internal consistency at both the total and subscale 
level and had satisfactory test-retest reliability. Both versions were correlated with 
worry and trait anxiety and had satisfactory concurrent validity. Significant 
differences between the scores of the clinical and non-clinical sample supported 
discriminant validity. Predictive validity was also supported for the two scales. Total 
scores, in the case of the clinical sample, and a subscale, in the case of the non-
clinical sample, significantly predicted pathological worry and trait anxiety. Overall, 
the clinicians and researchers can use either version of the IUS with confidence, due 
to their sound psychometric properties.  
Word count: 166 
Key words: Intolerance of uncertainty, anxiety and worry. 
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A Comparison of the 27-item and 12-item Intolerance of Uncertainty Scales. 
Intolerance of uncertainty was first described by Freeston, Rhéaume, Letarte, 
Dugas, and Ladouceur (1994) as being a key construct related to worry. It refers to a 
set of cognitive, emotional, and behavioural processes, which are involved in 
excessive, uncontrollable worry about future events. Intolerance of uncertainty has 
been one of the commonly used constructs in research into mood and anxiety 
disorders (Buhr & Dugas, 2006). The 27-item Intolerance of Uncertainty Scale (IUS) 
has been investigated and validated with various populations and has become one of 
the most used measures of intolerance of uncertainty (Buhr & Dugas, 2002; Freeston 
et al., 1994, Norton, 2005; Sexton & Dugas, 2009).  More recently, an abridged, 12 
item version of the IUS has been developed (Carleton, Norton, & Asmundson, 2007). 
The purpose of the current research is to compare the psychometric properties and 
clinical utility of the 27 and 12 item versions of the IUS.  
Development of the IUS 
In order to measure the construct of the intolerance of uncertainty (IU), 
Freeston et al. (1994) initially developed the Intolerance of Uncertainty scale (IUS) in 
the French language. This self-report scale consisted of 27 items, which supported a 
five factor structure. The items measured individuals’ emotional, cognitive and 
behavioural reactions to ambiguous and uncertain situations, such as stress and 
frustrations, as well as their attempts to control the future and their inability to act. 
Buhr and Dugas (2002) translated and back-translated the original IUS into English 
and evaluated the psychometric properties using statistical procedures similar to the 
French version. Results on this English version of the scale suggested a four-factor 
structure as the best representation of the construct. Both the French and the English 
versions of the IUS demonstrated excellent internal consistency ( = .94 and  = .91, 
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respectively) and good 5-week test-retest reliability (r = .78 and r = .74, respectively). 
Convergent and divergent validity were also evident. The French version (Freeston et 
al.,1994) differentiated Generalised Anxiety Disorder patients from those with other 
anxiety disorders and had a stronger association with the symptoms of worry than 
anxiety and depression. The English version (Buhr & Dugas, 2002) was associated 
with worry after taking into account anxiety and depression. Overall, their studies 
suggested that the 27-item IUS had good psychometric qualities for measuring 
intolerance of uncertainty. However, elevated correlations among the factors as well 
as the items suggested overlap at both factor and item level.  Buhr and Dugas (2002) 
concluded that the concept of intolerance of uncertainty was captured better by the 
overall scale. Therefore, they recommended using the total scale score, instead of the 
subscales score as an index of intolerance of uncertainty.  
Irrespective of the satisfactory psychometric properties of the scale, Norton 
(2005) argued that previous studies (Buhr and Dugas, 2002; Freeston et al, 1994) 
mainly examined the scale on Caucasian samples. Therefore, Norton conducted a 
psychometric analysis on 450 university students from four different cultural groups 
in the US (African American, Caucasian, Hispanic/Latino, and Southeast Asian). 
Statistical procedures used were in line with Buhr and Dugas (2002) study. Internal 
consistency was excellent with alpha coefficients over .93 within each racial group. 
All groups consistently demonstrated associations between IUS and worry. The 
results evidenced a strong cross-cultural consistency for the IUS; however, the factor 
structures differed across groups. Further, consistent with the overlap reported by 
Buhr and Dugas (2002), Norton found extensive cross-loading of items on multiple 
factors, thus making the interpretation of factors difficult. Norton recommended using 
the total IUS score as a best representation of the intolerance of uncertainty construct, 
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and suggested the possibility of item modification or reduction to improve the factor 
structure interpretability without a dramatic impact on the scale reliability.  
In line with Norton’s (2005) suggestions, Carleton et al. (2007) performed 
psychometric analyses on the English IUS to evaluate the possibility of a shorter 
version. Confirmatory factor analysis, using two undergraduate samples, identified a 
stable 12-item two factor structure (IUS-12) as the best representation of the IUS. The 
two factors were free from overlapping items. The first factor Inhibitory Anxiety 
consisted of five items and reflected beliefs about the negative nature of uncertainty 
and the manner in which it impairs a person’s functioning. The second factor 
Prospective Anxiety comprised seven items reflecting beliefs about the negative 
impact of uncertainty related to future events. Consistent with previous findings (Buhr 
& Dugas, 2002; Freeston et al., 1994; Norton, 2005), the total score of IUS-12 
maintained excellent internal consistency ( = .91). The alpha coefficients for both 
factors were .85. The correlation between the total score of the 12-item scale and the 
total score of 27-item scale was very high (r = .96). The correlation between the two 
factors was also high (r = .72). Despite fewer items, convergent validity was not 
substantially different from the previous studies and construct validity showed little or 
no change. No gender specific changes were identified and IU emerged as a construct 
which affected men and women alike. The IUS-12 correlated with depression, anxiety 
and worry measures and predicted GAD and pathological worry.  
In spite of the IUS-12’s promising qualities, Sexton and Dugas (2009) argued 
that although the two factors did not overlap, they did not reflect the underlying 
theory and the content of intolerance of uncertainty adequately. Subsequent 
exploratory factor analyses with over two thousand students and some community 
members as participants suggested a two-factor model based on the original 27-item 
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IUS as the best representation of the construct (Sexton & Dugas, 2009). These two 
factors were further upheld by confirmatory factor analysis. Factor one consisted of 
15 items. It was described as Uncertainty has Negative Behavioural and Self-referent 
Implications. It reflected beliefs that uncertainty impairs ones behaviour and capacity. 
Factor two consisted of 12 items and was described as Uncertainty is Unfair and 
Spoils Everything. It reflected beliefs about the distressing nature of uncertainty 
related to future events. The IUS overall scale and the two subscales showed excellent 
internal consistency with alphas over .90. These factors were correlated significantly 
with worry. Additionally, these factors also demonstrated distinct patterns of 
association with trait anxiety, depression, analogue GAD and somatic anxiety. The 
findings supported construct and divergent validity. Further investigations using the 
2-factor structure have revealed that the IUS has similar psychometric properties 
across gender and across the four ethnic groups compared (Sexton & Dugas, 2009). 
The Current Research 
There is substantial evidence that IU is related with worry and anxiety (Sexton 
& Dugas, 2009). Even though it was initially considered a vulnerability factor for 
GAD patients, its involvement has been extended to other anxiety disorders Dugas, 
Marchand, & Ladouceur, 2005). It is therefore important to continue the investigation 
of the IU scales. While previous research has examined both versions of the IUS 
separately using both non-clinical and clinical populations, investigations have yet to 
explore the use of the two versions simultaneously using clinical and non-clinical 
samples. Therefore, the aim of the current research was to empirically compare for the 
first time the two recent versions of the IUS (Carleton et al, 2007; Sexton & Dugas, 
2009), in order to identify the version with superior psychometric properties and 
better clinical utility. This research was exploratory in nature, with a focus on internal 
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consistency, test-retest, concurrent validity, discriminant validity and predictive 
validity in regards to worry and anxiety.  
Method 
Participants 
The sample comprised of both clinical and non-clinical individuals. The 
clinical group consisted of 50 participants including 20 males and 30 females aged 
between 20 and 65 years (M = 42.62, SD = 11.89). Twenty-six percent of the 
participants were diagnosed with GAD only and the remaining had the principle 
diagnoses of GAD with one or more than one co-morbid diagnoses including Panic 
Disorder, Post Traumatic Stress Disorder, Social Phobia, and Obsessive Compulsive 
Disorder. The educational level of this group consisted of participants with a 
University Degree (46%), TAFE (22%), High School (18%), or Other (12%). Two 
percent did not report their educational level. In terms of relationship status, 48% of 
participants were married, 28% were single, 2% were divorced, 16% were widowed, 
2% were co-habiting, and 2% did not report their relationship status. Most participants 
came from an English speaking background (92%), 6% spoke another language at 
home and 2% did not specify. 
The non-clinical individuals were 56 university students undertaking a 
psychology degree, some of whom received course credit for their participation. 
Participants included 12 males and 44 females aged between 17 and 52 years (M = 
27.02, SD = 11.26). Most (97%) of these participants were enrolled in a Bachelor 
degree and 7 % had were enrolled in Postgraduate education. In terms of marital 
status, 21.2 % of the participants were married, 55.4% were single, 5.4% were 
divorced, 5.4% were co-habiting and 12.5% reported other arrangements. The 
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majority of participants came from an English speaking background (76.8 %) and 
23.2% spoke another language at home. 
Measures 
The following measures were included in the battery to allow a comparison of 
the 2-factor IUS-27 and IUS-12 as well as to examine the associations of these two 
scales with other frequently used measures of worry and anxiety. 
Intolerance of Uncertainty Scale – 27-item (IUS-27). The revised IUS-27 with 
two factors was used (Sexton & Dugas, 2009). Items were scored on a 5-point Likert 
scale ranging from 1 (not at all characteristic of me) to 5 (entirely characteristic of 
me). The total scale has demonstrated excellent internal consistency with alpha 
coefficients of .95 (Sexton & Dugas, 2009) and good test-retest reliability of .74 over 
a five-week period (Dugas, Freeston & Ladouceur, 1997). It has also demonstrated 
satisfactory convergent and divergent validity (Buhr & Dugas, 2002; Freeston et al., 
1994; Sexton & Dugas, 2009). 
Intolerance of Uncertainty Scale – 12-item (IUS-12). The IUS-12 with two 
factors was used (Carleton et al., 2007). Items were scored on a five point scale 
ranging from 1 (Not at all characteristic of me) to 5 (Entirely characteristic of me). 
Carleton et al. found excellent internal consistency for this scale ( = .91), and a 
strong correlation between the 12-item IUS and the original 27-item IUS (r = .96). 
Anxious Thoughts Inventory (AnTI). This 22-item self-report measures three 
types of worries: social, health and meta-worry (Wells, 1994). Two of the types are 
content-related worry: worry about social affairs, and worry about physical health. 
The other worry type measured is process worry: meta-worry, or the negative 
appraisal of worry itself. Items are rated on a 4-point Likert scale ranging from 1 
(almost never) to 4 (almost always). Wells found high internal consistency for each of 
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the subscales ( = .84 for social worry, = .81 for health worry and  = .75 for meta-
worry). The test-retest reliabilities over a 6-week period for total score, social worry, 
health worry and meta-worry were .80, .76, .84 and .77, respectively.  
Meta-Cognitions Questionnaire – Short form (MCQ-30). The MCQ-30 (Wells 
& Cartwright-Hatton, 2004) is a multidimensional 30-item measure of meta-
cognitions. Items are rated on a 4-point Likert scale ranging from 1 (do not agree) to 
4 (agree very much) and tap the factors  Cognitive Confidence, Positive Beliefs, 
Cognitive Self-consciousness, Uncontrollability and Danger, and Need to Control 
Thoughts. Wells and Cartwright-Haddon found good internal consistency (α = .93), 
and test-retest reliability (r = .75) for the questionnaire. 
Penn State Worry Questionnaire (PSWQ). The PSWQ (Meyer, Miller, 
Metzger, & Borkovec, 1990) was designed to provide a trait assessment of 
pathological worry. Sixteen self-report items are rated on a 5-point Likert scale 
ranging from 1 (not at all typical of me) to 5 (very typical of me). The PSWQ taps a 
single factor with high internal consistency ( = .86 to .94) and good test-retest 
reliability over 8-10 weeks, r = .92. 
State Trait Anxiety Inventory Form Y-2 (STAI-T). The STAI-T (Spielberger, 
Gorsuch, Lushene, Vagg, & Jacobs, 1983) is the trait version of the State Trait 
Anxiety Inventory. The STAI-T is a widely used instrument consisting of 20 self-
report items reflecting dimensions of excessive worry, tension low self-esteem and 
demoralisation. Items are scored on a 4-point Likert scale ranging from 1 (almost 
never) to 4 (almost always). The STAI-T has good internal consistency with an alpha 
coefficient of .90, and test-retest reliability ranging from r = .73 to .86. 
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Procedure 
Participants in the clinical group were recruited as part of a larger study that 
compared the effectiveness of therapies with GAD and other anxiety disorders 
(Strodl, Schweitzer, Khawaja, & Young, 2009). The clinical sample was recruited via 
media releases including radio broadcasts and newspaper advertisements. Those who 
responded to the advertisements were informed about the purpose of the study. 
Individuals who volunteered to participate were screened through a telephone 
interview and scheduled for a face-to-face interview. Participants were required to 
meet the DSM-IV-TR criteria for Generalised Anxiety Disorders (GAD). A ninety 
minute structured interview, consisting of Mini-International Neuropsychiatric 
Interview (MINI) (Sheehan et al., 1998) as well as the section on GAD from the 
Anxiety Disorder Interview for DSM-IV’s (ADIS) (Margraf, Schneider, Ehlers, 
DiNardo, & Barlow, 1991), was conducted by trainee psychologists enrolled in 
Masters or Doctoral programs in clinical psychology. Participants between the age of 
18 to 65 years with the diagnosis of GAD only; or GAD co-morbid with other anxiety 
disorders were selected. Individuals with poor English language skills, poor memory, 
cognitive deficits, current substance dependence, or suffering from a psychotic illness 
were excluded.  
Randomly ordered questionnaires were administered and participants were 
debriefed at the end of the session. All participants were offered treatment. A few 
participants, who did not meet the criteria for the study, were referred to the university 
clinic or other places in the city for counselling offered at nominal rates. One 
participant decided to withdraw from the study. 
Non-clinical participants were recruited from the university. Consistent with 
the clinical group questionnaire administration was randomised, and participants were 
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debriefed at the end of the data collection session. These participants were also invited 
to participate in the second session (assessing test-retest reliability) two weeks later. 
Only the IUS-27 and IUS-12 scales were administered in the second session. 
Design 
The statistical analyses in this study focused on the reliability and validity of 
the two versions. Bivariate correlations were used to assess the concurrent validity. To 
examine the discriminant validity, t-tests were used to identify if there were gender 
based differences. Similarly, clinical and non-clinical samples were compared on the 
scales and the subscales. Standard multiple regressions were performed to evaluate 
predictive validity. The responses on the two subscales of IUS-27 (Uncertainty has 
Negative Implications and Uncertainty is Unfair) and IUS-12 (Inhibitory Anxiety and 
Prospective Anxiety) served as the independent variables in the model, while 
responses on the PSWQ, a frequently used measure of worry and STAI-T, a very 
commonly used measure of anxiety, were the dependent variables. 
Results 
Preliminary Analyses.  
All relevant statistical assumptions were met. In the clinical group, one 
participant did not provide all the demographic details but completed all the 
questionnaires; therefore, the questionnaire data for this case was retained. Similarly, 
in the clinical group, a procedural error resulted in some participants omitting item 15 
of the IUS-27. As a result, 30 missing data points were identified. Expectation 
maximisation was performed (Tabachnick & Fidell, 2001) and cases with missing 
data were replaced with the imputed values. Finally, 50 participants were retained in 
the analyses. The Cronbach’s alphas for the PSWQ, STAI-T, MCQ-30 and AnTI on 
the basis of the two samples (non-clinical in parentheses) were .87 (.80), .85 (.94), .88 
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(.92) and .90 (.92) respectively, indicating that these measures had good internal 
consistency.  
Reliability 
The internal consistency, for the total as well as the sub scales of the IUS-27 
and IUS-12, was calculated using the clinical and the non-clinical samples. The 
Cronbach’s alpha coefficients for the two scales and their subscales are presented in 
Table 1. Both versions of the IUS and their subscales demonstrated good internal 
consistency on the basis of the two samples.  
Please insert Table 1 here 
 Test-retest reliability was examined using the scores of the non-clinical sample 
over a two week interval. For the IUS-27 test-retest reliability was r = .83 and for the 
IUS-12 was r = .77, indicating satisfactory reliability. 
Concurrent Validity 
To evaluate the concurrent validity of the IUS-27, IUS-12 and their subscales, 
Pearson correlations were performed among the IUS and other measures of worry and 
anxiety using the clinical and the non-clinical samples. Table 2 presents the 
correlations based on the clinical and the non-clinical samples.  
Please insert Tables 2 here 
As indicated by Table 2, in the clinical population the total scores for the IUS-
27, IUS-12 and their subscales were significantly correlated with the PSWQ, STAI-T, 
MCQ-30 and AnTI. As seen by the table, the correlations ranged from low (r = .27 for 
Uncertainty is Unfair and AnTI) to moderate (r = .53 for IUS-12 and MCQ-30). The 
results indicate that two scales and their subscales were related with other scales 
measuring anxiety and worry. The IUS-27 and IUS-12 and their subscales had 
moderate to high correlations. As the items of the shorter version were drawn from 
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the original items, the total scores for the 27 and 12 items versions were correlated.  
The correlations between the two subscales in each version were moderate. Further, 
the Uncertainty has Negative Implications subscale of the IUS-27 and the Inhibitory 
Anxiety subscales of the IUS-12 were strongly associated and reflected a similar 
theme. Similarly the Uncertainty is Unfair subscale of the IUS-27 and the Prospective 
Anxiety subscale of the IUS-12 were strongly associated and reflected a similar theme. 
The PSWQ, STAI-T, MCQ-30 and AnTI were also significantly associated, except 
for the relationship between MCQ-30 and STAI-T, which was nominal. The modest 
relationships indicated that these study measures are distinct constructs but share 
some common features in measuring worry. 
As shown in Table 2, the total scores for the IUS-27, IUS-12 and their 
subscales in the non-clinical population were significantly correlated with the PSWQ, 
STAI-T, MCQ-30 and AnTI. The correlations ranged from moderate (r = .41 for 
PSWQ and Prospective Anxiety) to high (r = .73 for Inhibitory Anxiety and MCQ-
30). The two scales and their subscales were associated with other scales measuring 
anxiety and worry. The correlations between the two IUS scales and their subscales 
were high. The IUS-12 was highly correlated with the original version IUS-27. The 
correlations between the subscales of each version were also high. Further, the 
Uncertainty has Negative Implications subscale of the IUS-27 and the Inhibitory 
Anxiety subscales of the IUS-12 were strongly associated and indicated a similar 
theme, while the Uncertainty is Unfair subscale of the IUS-27 and the Prospective 
Anxiety subscale of the IUS-12 were strongly associated and revealed a similar theme. 
PSWQ, STAI-T, MCQ-30 and AnTi were also significantly associated. Overall, 
compared to the clinical sample, the correlations among the IUS-27, IUS-12, their 
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subscales and the anxiety and worry scales were generally higher for the non-clinical 
sample (Table 2). 
Discriminant Validity 
 Independent sample t-tests were conducted to investigate the scales ability to 
discriminate between men and women and the clinical and non-clinical samples.  In 
order to control for a family wise error rate a more stringent cut off value of p = .01 
was used. Results indicated no significant differences as a result of the gender. Table 
3 shows the means, standard deviations and the t values for the clinical and the non-
clinical groups. The clinical and the non-clinical groups were compared on the two 
versions of the scales as well as their subscales. There was a significant difference for 
the total scores of IUS-27 and IUS-12. This indicates that the scales were overall able 
to discriminate between the samples. Analyses using the subscales revealed that the 
two groups significantly differed on the scores for the two factors of IUS-27: 
Uncertainty has Negative Implication and Uncertainty is unfair. In the case of the 
shorter version, the two grouped significantly differed on one of the factor, Inhibitory 
anxiety but not the other.   
Please insert Table 3 here 
Predictive Validity 
Separate analyses were conducted on the clinical as well as the non-clinical 
samples. Age, which was not correlated with the other variables, was not controlled 
for in the regression analyses. The PSWQ and STAI-T were chosen to evaluate 
predictive validity as they are frequently used measures for excessive worry and 
anxiety commonly found in GAD patients. Table 4 present the results of the 
regression analyses. 
Please insert Table 4 here 
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Predictive Validity Analyses with Clinical Sample. First, the role of IUS as a 
predictor of pathological worry (PSWQ) was examined. Two separate analyses were 
conducted to evaluate the role of the IUS-27 and IUS 12 in predicting pathological 
worry on the clinical sample. The results of the first analysis revealed that the linear 
combination of the subscales of IUS-27 accounted for a significant amount of 
variance of pathological worry, R2 = .15, adjusted R2 = .12, F (2,47) = 4.20, p < .05. 
Further examination of the beta weights on each subscale, (Table 4), indicated that 
neither of the subscales made a significant contribution to the prediction of 
pathological worry. The results of the second analysis showed that the linear 
combination of the subscales of IUS-12 significantly predicted pathological worry, R2 
= .16, adjusted R2 = .12, F (2,47) = 4.31, p < .05; however, the beta weights suggest 
that neither of the subscales significantly predict pathological worry (Table 4). 
Overall, both the IUS-27 and IUS-12 yielded comparable outcomes and the overall 
models have similar effect in predicting pathological worry. However, individually, 
none of the subscales played a role in predicting pathological worry. All the subscales 
in both versions accounted for small unique variances from 1 to 7 percent, but the 
second subscales of both versions had slightly higher unique variances than the first 
subscales. 
Second, the role of IUS as a predictor of trait anxiety (STAI-T) was examined. 
Two separate analyses were run to evaluate the role of the IUS-27 and IUS-12 in 
predicting trait anxiety on the clinical sample. The results of the first analysis revealed 
that the linear combination of the subscales of IUS-27 accounted for a significant 
amount of variance of trait anxiety, R2 = .16, adjusted R2 = .13, F (2,47) = 4.55, p < 
.05. However, further examination of the beta weights on each subscale, presented in 
Table 4, found that none of the subscales significantly predicted trait anxiety. The 
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results of the second analysis showed that the linear combination of the two subscales 
of IUS-12 predicted trait anxiety significantly, R2 = .15, adjusted R2 = .11, F (2,47) = 
4.06, p < .05. Again, the beta weights indicated that none of the subscales 
significantly predicted trait anxiety (Table 4). Overall, both the IUS-27 and IUS-12 
yielded comparable outcomes and the overall models had similar effect in predicting 
trait anxiety. However, neither subscale in either version played a role in predicting 
the trait anxiety. All the subscales in both versions accounted for small unique 
variances from 2 to 5 percent, but the second subscales of both versions had slightly 
higher unique variances than the first subscales. 
Predictive Validity Analyses with Non-Clinical Sample. First, the role of IUS 
as a predictor of worry (PSWQ) was examined. Two separate analyses were 
conducted to evaluate the role of the IUS27 and IUS-12 in predicting worry on the 
non-clinical sample. The results of the first analysis revealed that the linear 
combination of the two subscales of IUS-27 accounted for a significant amount of 
variance of pathological worry, R2 = .47, adjusted R2 = .45, F (2,53) = 23.91, p < .001. 
Further examination of the beta weights on each subscale presented in Table 4 
indicated that the Uncertainty has Negative Implications subscale significantly 
predicted worry. The results of the second analysis showed that the linear 
combination of the two subscales of IUS-12 significantly predicted pathological 
worry, R2 = .47, adjusted R2 = .45, F (2, 53) = 23.08, p < .001. The Inhibitory Anxiety 
subscale significantly predicted worry (Table 4). Overall, only one of the subscales in 
both the IUS-27 and IUS-12 played a role in predicting worry; however, both versions 
yielded comparable outcomes and the overall models have similar effect in predicting 
worry. The Uncertainty has Negative Implications subscale of IUS-27 accounted for 
20% unique variance and the Inhibitory Anxiety subscale of IUS-12 accounted for 
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29% unique variance, whereas the Uncertainty is Unfair subscale of IUS-27 
accounted for 2% unique variance and the Prospective Anxiety subscale of IUS-12 
accounted 4% unique variance. 
Second, the role of IUS in the prediction of trait anxiety (STAI-T) was 
investigated. Two separate analyses were run to evaluate the role of the IUS-27 and 
IUs-12 in predicting trait anxiety on the non-clinical sample. The results of the first 
analysis revealed that the linear combination of the two subscales of IUS-27 
accounted for significant amount of variance of trait anxiety, R2 = .46, adjusted R2 = 
.44, F (2,53) = 22.82, p < .01. Further examination of the beta weights on each 
subscale showed that, in the case of the longer scale, the Uncertainty has Negative 
Implications subscale significantly predicted trait anxiety (Table 4). The results of the 
second analysis showed that the linear combination of the two subscales of IUS-12 
significantly predicted trait anxiety, R2 = .55, adjusted R2 = .53, F (2, 53) = 32.30, p < 
.001. The beta weights presented in Table 4 indicated that the Inhibitory Anxiety 
subscale of this shorter version was the stronger predictor. Overall, only one of the 
subscales in both the IUS-27 and IUS-12 contributed to the trait anxiety, therefore 
both versions yielded comparable outcomes and the overall models had similar effect 
in predicting trait anxiety. The Uncertainty has Negative Implications subscale of 
IUS-27 accounted for 14% unique variance and the Inhibitory Anxiety subscale of 
IUS-12 accounted for 32% unique variance, whereas the Uncertainty is Unfair 
subscale of IUS-27 accounted for 0% unique variance and the Prospective Anxiety 
subscale of IUS-12 accounted 3% unique variance. 
Discussion 
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The primary goal of this study was to compare the two different versions of 
the IUS (the IUS-27 and IUS-12) in order to identify the version with superior 
psychometric properties based on clinical and non-clinical samples.  
Internal Consistency 
The results indicated that the IUS-27 had a higher internal consistency than the 
IUS-12. However, the difference was very small. Subscales for both versions 
displayed good internal consistency, except for the Inhibitory Anxiety subscales of the 
IUS-12, which reported lower alpha coefficient than the similar subscale, Uncertainty 
has Negative Implications, in the IUS-27. It is important to note that the Uncertainty 
has Negative Implications subscale consists of 15 items whereas the Inhibitory 
Anxiety subscale has only 5 items derived from the longer subscale. It seems that 
scales and subscales with a larger number of items demonstrated higher internal 
consistency (Nunnally & Bernstein, 1994). In general, both the IUS-27 and IUS-12 
emerged as internally consistent and these findings concur with previous research on 
both the IUS-27 (e.g. Buhr & Dugas 2002; Freeston et al., 1994; Norton, 2005; 
Sexton & Dugas, 2009) and the IUS-12 (Carleton et al., 2007).  
Test-retest Reliability  
Test-retest was conducted on the non-clinical sample only and results 
indicated that both the IUS-27 and IUS-12 are stable over time. These test-retest 
reliability results are consistent with Dugas et al. (1997) and Freeston et al.’s (1994) 
findings. Overall, the current results suggest that the IUS-27 has slightly higher test-
retest reliability. Nevertheless, both versions were adequately stable and reliable 
overtime. 
Concurrent Validity 
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The IUS-27 and IUS-12 were compared with other anxiety and worry scales.  
Both versions were moderately correlated with the other scales and showed similar 
concurrent validity. A moderate level of correlation suggests that the IUS scales 
represent a unique construct that shares some aspects with other measures of anxiety 
and worry. Further, the subscales of the IUS-27 were moderately correlated with those 
measuring similar themes in the IUS-12. The correlations between the subscales in 
each measurement were moderate to high, indicating a large amount of covariance, 
consistent with previous research (Carleton et al., 2007; Sexton & Dugas, 2007, 
2009).  
Discriminant Validity 
 Consistent with the previous studies (Carleton et al., 2007, IU impacted men 
and women in a similar manner. However, the clinical sample scored higher than the 
non-clinical sample. The total scores of the scales differentiated the two groups. 
Similarly, the clinical sample scored significantly higher than the non-clinical 
participants on the two subscales of the longer version as well as the Inhibitory 
Anxiety subscale of the shorter version. The mean scores of the two groups did not 
differ for the subscale Prospective Anxiety, which takes into account the anxiety and 
uncertainty related to future events. It is possible that this dimension impacts 
individuals, with and without clinical anxiety and pathological worries, in a similar 
manner. It is important to note that the discriminant validity of the ISU-12 was not 
assessed by the authors (Carleton et al., 2007), therefore more investigation is 
warranted.  
Predictive Validity 
Both the IUS-27 and the IUS-12 were associated with various aspects of 
anxiety and worry as measured by PSWQ and STAI-T. Overall, both scales showed 
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similar relationships and were equally good at predicting worry and anxiety. The 
results were consistent with previous research using the original IUS with clinical and 
non-clinical samples (Dugas et al., 2005). Similarly, the findings were consistent with 
recent investigations using shortened versions of IUS with university student and 
community samples (Sexton & Dugas, 2009). 
 However, when examining the predictive validity of the subscales, different 
patterns of predictors emerged for the clinical and the non-clinical samples. In the 
clinical sample, none of the subscales in either of the two versions emerged as a 
stronger predictor of pathological worry or trait anxiety. The findings indicated that in 
the case of individuals experiencing anxiety disorders, beliefs of uncertainty related to 
their own self as well as future were equally associated with their worry and trait 
anxiety. In addition, due to the large amount of shared variance between the subscales 
it is recommended that when using the IUS with clinical population, the total score is 
more likely to provide an appropriate measure. This is consistent with the suggestions 
of Buhr and Dugas (2002) and Norton (2005).  
On the other hand, analyses conducted on the non-clinical sample indicated 
that only one of the subscales on IUS-27 (Uncertainty has Negative Implications) and 
IUS-12 (Inhibitory anxiety) measuring a similar theme was significantly associated 
with worry and trait anxiety. The results indicated that in the case of individuals who 
were not experiencing anxiety disorders, only beliefs of uncertainty related to their 
functioning were associated with worry and trait anxiety. It seemed that the non-
clinical sample, compared to the clinical sample, was less bothered by uncertainty 
about the future and its distressing nature. However, until more research is conducted 
the separate use of subscales should be treated cautiously with the non-clinical 
population.  
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A close examination of the regression coefficients revealed that in the case of 
non-clinical sample the IU scales explained nearly half of the variance for the 
pathological worry and trait anxiety. However, a different picture appeared for the 
clinical sample. IU explained a small amount of the variance. It is possible that other 
factors, along with IU, explain the clinical conditions of anxiety and worry.    
Limitations and Future Directions 
Although this research is the first to investigate both versions of the IUS 
simultaneously in clinical and non-clinical samples, it is not without limitations. The 
non-clinical sample was not assessed to rule out any the presence of any anxiety 
disorder. Future studies are recommended to use a diagnostic interview to exclude 
those with psychopathology. The information about the test-retest of the scales is only 
available for the non-clinical population. Therefore, there is a need to evaluate the 
stability of these scales by using a clinical sample. The samples were small and the 
inter-rater reliability data were not available regarding the diagnoses for the clinical 
sample. Even though the clinical sample included met the diagnostic criteria for GAD, 
the participants were self referred and recruited from the community. Therefore, their 
motivation and expectations may have impacted on the results. Further, participants 
recruited from clinical settings could have more severe symptomology. As such, the 
findings from the current research may not be fully generalisable to clinical 
populations. Future studies could consider focusing on participants from clinical 
settings, and separating individuals with GAD from those with co-morbid mood and 
anxiety disorders.  Further, keeping in view the previously noted inconsistencies in 
factor structure among different cultural groups (Norton, 2005), more research on 
factor structure, using large and diverse populations would be beneficial. The 
discriminant validity requires further investigation. The relative importance of the 
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subscales as predictors could also be examined using larger samples. Further 
evaluation of the role of these predictors in the aetiology and maintenance of worry 
and anxiety may allow clinicians to develop more effective treatment programs for 
those experiencing conditions.  
Conclusion 
This research aimed to investigate the psychometric properties of two versions 
of the IUS in clinical and non-clinical populations. The results indicate that both the 
IUS-27 and IUS-12 are statistically sound and have satisfactory psychometric 
properties. While the IUS-27 has slightly better reliability, the IUS-12 is a more 
economical instrument to use. The shorter instrument may be particularly beneficial 
when participants or patients are required to complete a battery of questionnaires. 
Both versions of the IUS are equally effective in the measurement of Intolerance of 
Uncertainty. Given the similar properties of the IUS-27 and the IUS-12, clinicians and 
researchers may choose either version without any serious limitations.  
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Table 1 
Cronbach’s Alphas for the IUS-27 and IUS-12 in Clinical and Non Clinical Samples 
 Clinical (n=50) Non-Clinical (n=56) 
IUS-27 
IUS-27 F1 
IUS-27 F2 
IUS-12 
IUS-12 F1 
IUS-12 F2 
.93 
.90 
.88 
.87 
.72 
.86 
.95 
.92 
.92 
.92 
.89 
.86 
Note. IUS-27: 27-item Intolerance of Uncertainty Scale; IUS-27 F1: Uncertainty has 
Negative Implications; IUS-27 F2: Uncertainty is Unfair; IUS-12: 12-item Intolerance 
of Uncertainty Scale; IUS-12 F1: Inhibitory Anxiety and IUS-12 F2: Prospective 
Anxiety. 
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Table 2 
Concurrent validity for the IUS-27 and IUS-12          
 
Pearson correlations using Non-clinical (above the diagonal) and Clinical 
(below the diagonal) samples 
 
 
 
1 2 3 4 5 6 7 8 9 10 
1.IUS-27  .96 .97 .96 .93 .89 .62 .64 .72 .67 
2.IUS-12 .94  .91 .96 .94 .95 .54 .60 .71 .63 
3.IUS-27 F1 .92 .78  .87 .94 .80 .67 .66 .72 .68 
4.IUS-27 F2 .87 .94 .61  .86 .96 .52 .55 .68 .59 
5.IUS-12 F1 .87 .83 .90 .64  .81 .65 .71 .73 .69 
6.IUS-12 F2 .82 .93 .56 .97 .58  .41 .45 .64 .52 
7.PSWQ .36 .38 .29 .38 .33 .36  .76 .67 .71 
8.STAI-T .39 .38 .34 .37 .30 .36 .62  .71 .75 
9.MCQ-30 .49 .53 .40 .49 .45 .49 .35 .19  .61 
10.AnTI .49 .40 .58 .27 .48 .27 .28 .36 .52 
  
Note. Non-clinical sample n: 50; Clinical sample n: 56; IUS-27: 27-item Intolerance 
of Uncertainty Scale; IUS-12: 12-item Intolerance of Uncertainty Scale; IUS-27 
Factor 1: Uncertainty has Negative Implication; IUS-27 Factor 2: Uncertainty is 
Unfair; IUS-12 Factor 1: Inhibitory Anxiety; IUS-12 Factor 2: Prospective Anxiety;  
PSWQ: Penn State Worry Questionnaire; STAI-T: State Trait Anxiety Inventory for 
Adult Form Y-2; MCQ-30: 30-item Meta-Cognitions Questionnaire; AnTI: Anxious 
Thoughts Inventory; All correlations are significant at p < .05 (2-tailed) except the 
relationship between MCQ-30 and STAI-T in the clinical sample. 
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Table 3 
Means, Standard Deviation and the Group differences for the IUS-27 and IUS-12 
  Clinical   Non-Clinical  t p 
  M (SD)  M (SD) 
IUS-27 Total 80.24 (18.26)  66.58(21)  3.55 .001 
IUS-27 F1 2.86(.75)  2.28(.75)  3.97 .001 
IUS-27 F2 3.10 (.75)  2.69(.86)  2.56 .01 
IUS-12 Total 36.76 (8.72)  30.62 (9.98)  3.35 .001 
IUS-12 F1 2.96 (.76)  2.18 (.85)  4.93 .001 
IUS-27 F2 3.13(.84)  2.81(.91)  1.86 .06 
Note. IUS-27: 27-item Intolerance of Uncertainty Scale; IUS-27 Factor 1: Uncertainty 
has Negative Implication; IUS-27 Factor 2: Uncertainty is Unfair; IUS-12: 12-item 
Intolerance of Uncertainty Scale; IUS-12 Factor 1: Inhibitory Anxiety; IUS-12 Factor 
2: Prospective Anxiety; Clinical sample n: 50; Non-Clinical sample n: 56;  t values 
are significant at p < .01 (2-tailed) and df: 104. 
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Table 4 
Standard Multiple Regression Analyses for the Subscales of IUS-27 and IUS-12  
Measures B SE B  T sri2 (unique)
 
Predicting Pathological Worry (PSWQ)  
(Clinical Sample) 
 
IUS-27 subscales     
– Uncertainty has Negative Implications1 .09 .16 .09 0.54 .01 
– Uncertainty is Unfair2 .38 .20 .33 1.90 .07 
IUS-12 subscales       
– Inhibitory Anxiety1 .55 .46 .20 1.19 .03 
– Prospective Anxiety2 .44 .30 .25 1.48 .04 
 
Predicting Trait Anxiety (STAI-T) 
(Clinical Sample) 
 
IUS-27 subscales     
– Uncertainty has Negative Implications1 .10 .10 .18 1.05 .02 
– Uncertainty is Unfair2 .19 .12 .27 1.58 .04 
IUS-12 subscales       
– Inhibitory Anxiety1 .26 .28 .15 0.93 .02 
– Prospective Anxiety2 .29 .18 .27 1.64 .05 
 
Predicting Pathological Worry (PSWQ) 
(Non-Clinical Sample) 
 
IUS-27 subscales     
– Uncertainty has Negative Implications1 1.14 .25 .94 4.54** .20 
– Uncertainty is Unfair2 -.41 .28 -.30 -1.45 .02 
IUS-12 subscales       
– Inhibitory Anxiety1 3.05 .57 .93 5.39** .29 
– Prospective Anxiety2 -5.24 2.63 -.34 -1.99* .04 
 
Predicting Trait Anxiety (STAI-T) 
(Non-Clinical Sample) 
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IUS-27 subscales     
– Uncertainty has Negative Implications1 .76 .21 .76 3.67** .14 
– Uncertainty is Unfair2 -.11 .23 -.10 -.47 .00 
IUS-12 subscales       
– Inhibitory Anxiety1 2.59 .42 .97 6.13** .32 
– Prospective Anxiety2 -3.88 1.97 -.31 -1.97* .03 
Note. IUS-27: 27-item Intolerance of Uncertainty Scale; IUS-12: 12-item Intolerance 
of Uncertainty Scale; STAI-T: State Trait Anxiety Inventory for Adult Form Y-2. 
1 measure similar theme & 2 measure similar theme. 
**p < .01; *p < .05. 
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